These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25469790)

  • 21. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease.
    Yilmaz Y; Eren F
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1292-5. PubMed ID: 25171027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that human autoimmune thrombocytopenia mediated by both immunoglobulin isotypes IgM and IgG is an independent disease entity.
    Stahl D; Hoemberg M; Cassens U; Pachmann U; Sibrowski W
    Eur J Haematol; 2005 Oct; 75(4):318-27. PubMed ID: 16146538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.
    Estep M; Armistead D; Hossain N; Elarainy H; Goodman Z; Baranova A; Chandhoke V; Younossi ZM
    Aliment Pharmacol Ther; 2010 Aug; 32(3):487-97. PubMed ID: 20497147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients.
    Everly MJ; Rebellato LM; Haisch CE; Briley KP; Bolin P; Kendrick WT; Kendrick SA; Morgan C; Maldonado AQ; Harland RC; Terasaki PI
    Transplantation; 2014 Mar; 97(5):494-501. PubMed ID: 24487396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
    Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
    J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.
    El Bassat H; Ziada DH; Hasby EA; Nagy H; Abo Ryia MH
    Arab J Gastroenterol; 2014 Mar; 15(1):6-11. PubMed ID: 24630506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
    Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
    Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.
    Blomme B; Francque S; Trépo E; Libbrecht L; Vanderschaeghe D; Verrijken A; Pattyn P; Nieuwenhove YV; Putte DV; Geerts A; Colle I; Delanghe J; Moreno C; Gaal LV; Callewaert N; Vlierberghe HV
    Dig Liver Dis; 2012 Apr; 44(4):315-22. PubMed ID: 22119618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.
    Sharma H; Estep M; Birerdinc A; Afendy A; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1410-5. PubMed ID: 23663110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Pittoni M; Bontadi A; Tonello M; Salvan E; Plebani M; Punzi L
    Clin Chim Acta; 2012 May; 413(9-10):911-3. PubMed ID: 22349599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intrahepatic B cells in non-alcoholic fatty liver disease by secreting pro-inflammatory cytokines and regulating intrahepatic T cells.
    Zhang F; Jiang WW; Li X; Qiu XY; Wu Z; Chi YJ; Cong X; Liu YL
    J Dig Dis; 2016 Jul; 17(7):464-74. PubMed ID: 27216040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease.
    Karrar A; Rajput B; Hariharan S; Abdelatif D; Houry M; Moosvi A; Ali I; Tan D; Noor S; Esmaeili D; Felix S; Alaparthi L; Otgonsuren M; Lam B; Goodman ZD; Younossi ZM
    Hepatol Commun; 2021 Jan; 5(1):63-73. PubMed ID: 33437901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
    Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
    Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
    Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
    Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
    Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.